​​​​​Objectives

1. Describe the pathophysiology of type 2 diabetes and cardiovascular disease 
2. Review the evidence for the use of GLP-1 in type 2 diabetes and cardiovascular disease
3. Review the evidence for the use of SGLT2 inhibitors in type 2 diabetes and cardiovascular disease
4. Compare and contrast the GLP1 and SGLT2 medications to recommend the best treatment option.

Webex:

GRILL Presentation

Hosted by Christian Kroll

Tuesday, Sep 3, 2019 11:00 am | 2 hours | (UTC-06:00) Central Time (US & Canada)

Occurs every Tuesday effective 9/3/2019 until 5/26/2020 from 11:00 AM to 1:00 PM, (UTC-06:00) Central Time (US & Canada)

Meeting number: 801 212 142

Password: GRILL

https://uwhealth.webex.com/uwhealth/j.php?MTID=m5419990fae08cafb392bf19e4f6d6646

Join by video system

Dial 801212142@uwhealth.webex.com

You can also dial 173.243.2.68 and enter your meeting number.

Join by phone

+1-415-655-0003 US TOLL

Access code: 801 212 142

Thanks!

Christian